fengdr
Curium is in advanced discussions to purchase radiopharma company Lantheus Holdings (LNTH) in a transaction that could be announced in the coming days.
Curium, which is backed by CapVest Partners, is expected to pay ~$102 a share upfront and an additional $12.50 per share
